U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559903) titled 'ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)' on April 24.
Brief Summary: The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Study Start Date: May, 2026
Study Type: OBSERVATIONAL
Condition:
Coronary Artery Disease
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Emory University
Information provided by (Resp...